New additions to Medtronic's product range
This article was originally published in Clinica
Medtronic has received US FDA clearance to market its Sprint 6932 ICD leads and has launched a cerebral catheter. Introduced in Europe in May, the 6932 is the first of a new family of defibrillator leads for active-can devices that feature multiple lumens and narrower conductors. The 7.8F lead uses Medtronic's tined, steroid-eluting electrode. Clinical trials of the 6942, a triple-lumen lead for defibrillating both the right ventricle and the superior vena cava, began in Europe in July. An active fixation version (6943) is expected to enter trials in the near future.